• Business Wire

    Infraredx, Inc., a cardiovascular imaging company advancing the diagnosis and treatment of coronary artery disease, announced that today it launched a road show for its initial public offering (“IPO”). Infraredx is offering 4.0 million shares of its common stock, and underwriters will have a 30-day option to buy an additional 600,000 shares. The IPO price